↓ Skip to main content

Trastuzumab containing regimens for early breast cancer

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
13 news outlets
blogs
2 blogs
policy
2 policy sources
twitter
56 X users
patent
2 patents
facebook
3 Facebook pages
wikipedia
1 Wikipedia page
googleplus
1 Google+ user

Citations

dimensions_citation
534 Dimensions

Readers on

mendeley
514 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Trastuzumab containing regimens for early breast cancer
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd006243.pub2
Pubmed ID
Authors

Lorenzo Moja, Ludovica Tagliabue, Sara Balduzzi, Elena Parmelli, Vanna Pistotti, Valentina Guarneri, Roberto D'Amico

Abstract

Approximately one-fifth of women who develop early breast cancer have HER2-positive tumours, which if untreated, have a worse prognosis than HER2-negative tumours. Trastuzumab is a selective treatment targeting the HER2 pathway. Although the results on efficacy seem to support its use, there are potential cardiac toxicities which need to be considered, especially for women at lower risk of recurrence, or those at increased cardiovascular risk.

X Demographics

X Demographics

The data shown below were collected from the profiles of 56 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 514 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 3 <1%
Canada 3 <1%
Korea, Republic of 2 <1%
United States 2 <1%
Chile 1 <1%
United Kingdom 1 <1%
Austria 1 <1%
Greece 1 <1%
Brazil 1 <1%
Other 0 0%
Unknown 499 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 58 11%
Student > Master 58 11%
Student > Bachelor 58 11%
Student > Ph. D. Student 47 9%
Student > Postgraduate 46 9%
Other 94 18%
Unknown 153 30%
Readers by discipline Count As %
Medicine and Dentistry 210 41%
Biochemistry, Genetics and Molecular Biology 26 5%
Agricultural and Biological Sciences 26 5%
Pharmacology, Toxicology and Pharmaceutical Science 21 4%
Nursing and Health Professions 17 3%
Other 49 10%
Unknown 165 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 160. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2024.
All research outputs
#254,357
of 25,374,647 outputs
Outputs from Cochrane database of systematic reviews
#420
of 11,484 outputs
Outputs of similar age
#1,059
of 174,271 outputs
Outputs of similar age from Cochrane database of systematic reviews
#4
of 173 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,484 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 39.9. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,271 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 173 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.